PneumoNP is a collaborative research program funded under the Seventh Framework Programme, with a €5.7 million grant. Starting in 2014, it is aiming at the development of a theragnostic system for the treatment of Gram-negative bacterial infections of the lung, with focus on Klebsiella pneumoniae caused infections.
Latest news from PneumoNP
From 10 to 14 July, around 150 researchers gathered at Jacobs University Bremen to discuss novel approaches to fight bacteria ...Read More
The antimicrobial peptide M33 may be the long-sought substitute to treat difficult lung infections, like multi-drug resistant pneumonia. In 2013, ...Read More